Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
07/28/1998 | US5785995 Antiarrhythmia agents and cardiovascular disorders |
07/28/1998 | US5785994 Osmotic dosage form for controlled drug release |
07/28/1998 | US5785993 Reduction of adhesions using controlled delivery of active oxygen inhibitors |
07/28/1998 | US5785992 Liposomes and cationic compounds |
07/28/1998 | US5785991 Transdermal drug delivery |
07/28/1998 | US5785988 Composition for freshening nostrils and sinus cavities |
07/28/1998 | US5785987 Method for loading lipid vesicles |
07/28/1998 | US5785986 Water channel |
07/28/1998 | US5785985 Moisture vapor transmission; bonding strength |
07/28/1998 | US5785977 A stable dispersant in a liquid carrier for drug or cosmetic uses |
07/28/1998 | US5785976 Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof |
07/28/1998 | US5785955 Hemostatic compositions for treating soft tissue |
07/28/1998 | US5785950 Perfluorobis(chlorobutyl ether; medical imaging |
07/24/1998 | CA2227314A1 Preparation of concealed taste preparations of antibacterially active quinolone derivatives |
07/23/1998 | WO1998031739A1 A process for preparing polymeric microgels |
07/23/1998 | WO1998031699A1 Crystal form 0 of clarithromycin |
07/23/1998 | WO1998031406A1 Holistic breast patch |
07/23/1998 | WO1998031402A2 Dressings |
07/23/1998 | WO1998031398A1 Microparticles for delivery of nucleic acid |
07/23/1998 | WO1998031386A1 Method for stabilizing peptides and freeze-dried medicinal compositions containing peptides obtained by using the method |
07/23/1998 | WO1998031369A1 External preparations for percutaneous absorption |
07/23/1998 | WO1998031368A1 Dosage forms and method for ameliorating male erectile dysfunction |
07/23/1998 | WO1998031365A1 Paroxetine compositions |
07/23/1998 | WO1998031361A1 Pharmaceutical composition of fenofibrate with high biological availability and method for preparing same |
07/23/1998 | WO1998031360A1 Pharmaceutical composition having high bioavailability and method for preparing it |
07/23/1998 | WO1998031353A1 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof |
07/23/1998 | WO1998031352A1 New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |
07/23/1998 | WO1998031351A1 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising formoterol |
07/23/1998 | WO1998031350A1 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising budesonide |
07/23/1998 | WO1998031349A1 Transdermal, hormone-delivering therapeutic system |
07/23/1998 | WO1998031348A1 Transdermal, acetylsalicylic acid-containing therapeutic system with reinforced resorption |
07/23/1998 | WO1998031347A1 Production of new polymer liquid crystals capable of having an interaction with liposomes |
07/23/1998 | WO1998031346A1 Preparation of particles for inhalation |
07/23/1998 | WO1998031344A1 Taste masking for unpalatable formulations |
07/23/1998 | WO1998031343A2 Aqueous suspension for nasal administration of loteprednol |
07/23/1998 | WO1998031342A1 Effervescent microspheres and method for making them |
07/23/1998 | WO1998031341A1 Expandable gastro-retentive therapeutic system with controlled active substance release in the gastro-intestinal tract |
07/23/1998 | WO1998031339A1 Skin preparation |
07/23/1998 | WO1998031315A1 Fillable patch for dermal or transdermal delivery |
07/23/1998 | WO1998025642A3 Pharmaceutical formulations comprising a water-insoluble complex for sustained drug delivery |
07/23/1998 | WO1998020869A3 Formulation for electrically assisted delivery of lidocaine and epinephrine |
07/23/1998 | WO1998018500A3 Improvements in or relating to diagnostic/therapeutic agents |
07/23/1998 | DE19732015C1 Self-emulsifying formulation useful in production of cosmetics, e.g. hair conditions |
07/23/1998 | CA2419499A1 Crystal form 0 of clarithromycin |
07/23/1998 | CA2278567A1 Production of new polymer liquid crystals capable of having an interaction with liposomes |
07/23/1998 | CA2278450A1 Microparticles for delivery of nucleic acid |
07/23/1998 | CA2278289A1 Dressings |
07/23/1998 | CA2278199A1 Method for stabilizing peptides and freeze-dried medicinal compositions containing peptides obtained by using the method |
07/23/1998 | CA2277831A1 Taste masking for unpalatable formulations |
07/23/1998 | CA2277480A1 Paroxetine compositions |
07/23/1998 | CA2277366A1 Transdermal, acetylsalicylic acid-containing therapeutic system with reinforced resorption |
07/23/1998 | CA2276758A1 Dosage forms and method for ameliorating male erectile dysfunction |
07/22/1998 | EP0853945A1 Liquid gonadotropin containing formulations |
07/22/1998 | EP0853943A1 Antiallergic agent |
07/22/1998 | EP0853921A2 Laser assisted drug delivery |
07/22/1998 | EP0853660A1 Method for preserving infectious recombinant viruses, aqueous viral suspension and use as medicine |
07/22/1998 | EP0853494A1 Oil-water emulsifiers |
07/22/1998 | EP0853476A2 Pharmaceutical preparation containing nimesulide for topical use |
07/22/1998 | EP0853474A2 Chemo-mechanical expansion delivery system |
07/22/1998 | EP0853473A1 Liposomes preparation method and plant |
07/22/1998 | EP0794767B1 Stable budesonide solutions, method of preparing them and use of these solutions as enema preparations and pharmaceutical foams |
07/22/1998 | EP0760644B1 Formulation preparation device |
07/22/1998 | EP0612256B1 Apparatus for partial liquid ventilation using fluorocarbons |
07/22/1998 | EP0610502B1 Emulsion containing parathyroid hormone for pernasal administration |
07/22/1998 | EP0608322B1 Enhanced skin penetration system for improved topical delivery of drugs |
07/22/1998 | EP0575613B1 Use of the amino acid glycine for the preparation of a medicament with antistress-, stress-preventive and nootropic action |
07/22/1998 | EP0557385B1 Topical compositions for transdermal delivery of produg derivatives of morphine |
07/22/1998 | EP0415999B1 Compositions having use as treatment of psoriasis and neuropsychiatric deficits |
07/22/1998 | CN1188420A Pharmaceutical powder cartridge with integrated metering device and inhaler for powdered medicaments |
07/22/1998 | CN1188418A Vaccine composition comprising polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
07/22/1998 | CN1188414A Novel formulation for peptide release |
07/22/1998 | CN1188411A Compressed dry-granulation desogestrel tablets |
07/22/1998 | CN1188408A Novel 'burst-free' sustained release poly-(lactide/glycolide) mi crospheres |
07/22/1998 | CN1188407A New pharmaceutical composition with anaesthetic effect |
07/22/1998 | CN1188014A Drug for curing arrhythmia |
07/22/1998 | CN1188009A Traditional Chinese medicine cold-preventing germicidal fragrance fog and its preparing method |
07/22/1998 | CN1188005A Chinese herbal medicine oral liquor for curing wind-heat common cold and its preparing method |
07/22/1998 | CN1188003A Process for preparing cold defervescent powder by using flocculating method |
07/22/1998 | CN1187991A Calcium tablet |
07/22/1998 | CN1039195C Gastric slow-released preparation of curing gastrosia by killing pyloric spirillum |
07/22/1998 | CN1039194C Improved pulsatile once-a-day-delivery systems for minocycline |
07/21/1998 | US5783691 Crosslinked hyaluronate gels, their use and method for producing them |
07/21/1998 | US5783592 Formulations for lipophilic compounds |
07/21/1998 | US5783589 2-saccharinylmethyl aryl and arloxy acetates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
07/21/1998 | US5783569 An immunostimulant which does not cause fever or inflammation, derived from yeast, wound healing |
07/21/1998 | US5783567 Microparticles for delivery of nucleic acid |
07/21/1998 | US5783565 Cationic amphiphiles containing spermine or spermidine cationic group for intracellular delivery of therapeutic molecules |
07/21/1998 | US5783559 Solution containing IGF-1 |
07/21/1998 | US5783556 Formulated insulin-containing composition |
07/21/1998 | US5783555 Storge stability; trypsin inhibitor; stabilizer is selected form basic or acidic amino acids and salts, gelatin, albumin, disaccharides and sugar alcohol |
07/21/1998 | US5783215 Pharmaceutical preparation |
07/21/1998 | US5783214 Bio-erodible matrix for the controlled release of medicinals |
07/21/1998 | US5783213 Cellulose acetate butyrate |
07/21/1998 | US5783212 Multiple barrier layers, zero-order release, swellable, erodible polymer, polyoxyethylene glycol, hydroxypropyl methyl cellulose |
07/21/1998 | US5783211 Liposome encapsulated active agent dry powder composition |
07/21/1998 | US5783210 Purification using silica gel chromatography |
07/21/1998 | US5783208 Transdermal drug delivery matrix for coadministering estradiol and another steroid |
07/21/1998 | US5783207 Holder for soluble matrix containing controlled amounts of nicotine as a cigarette replacement for treatment of nicotine withdrawal |
07/21/1998 | US5783205 Heating a bioerodible oligomer or polymer containing drug and introducing it into a diseased tissue pocket, such as a periodontal pocket |
07/21/1998 | US5783202 Consists of purified water, propylene glycol, nonionic emulsifying wax, ethoxylataed quatenary ammonium phosphate salt, pyrethrins, piperonyl butoxide, ethanol, propane/butane; insecticide |